These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 32139154)
1. Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant. Yuzefpolskaya M; Bohn B; Nasiri M; Zuver AM; Onat DD; Royzman EA; Nwokocha J; Mabasa M; Pinsino A; Brunjes D; Gaudig A; Clemons A; Trinh P; Stump S; Giddins MJ; Topkara VK; Garan AR; Takeda K; Takayama H; Naka Y; Farr MA; Nandakumar R; Uhlemann AC; Colombo PC; Demmer RT J Heart Lung Transplant; 2020 Sep; 39(9):880-890. PubMed ID: 32139154 [TBL] [Abstract][Full Text] [Related]
2. Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis. Yuzefpolskaya M; Bohn B; Javaid A; Mondellini GM; Braghieri L; Pinsino A; Onat D; Cagliostro B; Kim A; Takeda K; Naka Y; Farr M; Sayer GT; Uriel N; Nandakumar R; Mohan S; Colombo PC; Demmer RT Circ Heart Fail; 2021 Jun; 14(6):e007909. PubMed ID: 34129361 [TBL] [Abstract][Full Text] [Related]
3. Alterations in the sarcopenia index are associated with inflammation, gut, and oral microbiota among heart failure, left ventricular assist device, and heart transplant patients. Yuzefpolskaya M; Bohn B; Ladanyi A; Pinsino A; Braghieri L; Carey MR; Clerkin K; Sayer GT; Latif F; Koji T; Uriel N; Nandakumar R; Uhlemann AC; Colombo PC; Demmer RT J Heart Lung Transplant; 2024 May; ():. PubMed ID: 38744352 [TBL] [Abstract][Full Text] [Related]
4. Oral and gut microbiome alterations in heart failure: Epidemiology, pathogenesis and response to advanced heart failure therapies. Yuzefpolskaya M; Bohn B; Ladanyi A; Khoruts A; Colombo PC; Demmer RT J Heart Lung Transplant; 2023 Mar; 42(3):291-300. PubMed ID: 36586790 [TBL] [Abstract][Full Text] [Related]
5. Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation. Jennings DL; Bohn B; Zuver A; Onat D; Gaine M; Royzman E; Hupf J; Brunjes D; Latif F; Restaino S; Garan AR; Topkara VK; Takayama H; Takeda K; Naka Y; Farr M; Nandakumar R; Uhlemann AC; Colombo PC; Demmer RT; Yuzefpolskaya M PLoS One; 2020; 15(5):e0233646. PubMed ID: 32469966 [TBL] [Abstract][Full Text] [Related]
6. Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. Lee SH; Doliba N; Osbakken M; Oz M; Mancini D J Thorac Cardiovasc Surg; 1998 Aug; 116(2):344-9. PubMed ID: 9699589 [TBL] [Abstract][Full Text] [Related]
7. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation. Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, DNA damage and repair in heart failure patients after implantation of continuous flow left ventricular assist devices. Mondal NK; Sorensen E; Hiivala N; Feller E; Griffith B; Wu ZJ Int J Med Sci; 2013; 10(7):883-93. PubMed ID: 23781134 [TBL] [Abstract][Full Text] [Related]
9. High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry. Ambardekar AV; Forde-McLean RC; Kittleson MM; Stewart GC; Palardy M; Thibodeau JT; DeVore AD; Mountis MM; Cadaret L; Teuteberg JJ; Pamboukian SV; Cantor RS; Lindenfeld J J Heart Lung Transplant; 2016 Jun; 35(6):722-30. PubMed ID: 26987599 [TBL] [Abstract][Full Text] [Related]
10. Effect of left ventricular assist device implantation and heart transplantation on habitual physical activity and quality of life. Jakovljevic DG; McDiarmid A; Hallsworth K; Seferovic PM; Ninkovic VM; Parry G; Schueler S; Trenell MI; MacGowan GA Am J Cardiol; 2014 Jul; 114(1):88-93. PubMed ID: 24925802 [TBL] [Abstract][Full Text] [Related]
11. Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry. Ambardekar AV; Kittleson MM; Palardy M; Mountis MM; Forde-McLean RC; DeVore AD; Pamboukian SV; Thibodeau JT; Teuteberg JJ; Cadaret L; Xie R; Taddei-Peters W; Naftel DC; Kirklin JK; Stevenson LW; Stewart GC J Heart Lung Transplant; 2019 Apr; 38(4):408-417. PubMed ID: 30948210 [TBL] [Abstract][Full Text] [Related]
12. Systemic Inflammatory Response Syndrome in End-Stage Heart Failure Patients Following Continuous-Flow Left Ventricular Assist Device Implantation: Differences in Plasma Redox Status and Leukocyte Activation. Mondal NK; Sorensen EN; Pham SM; Koenig SC; Griffith BP; Slaughter MS; Wu ZJ Artif Organs; 2016 May; 40(5):434-43. PubMed ID: 26416627 [TBL] [Abstract][Full Text] [Related]
13. Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome. Takeda K; Takayama H; Colombo PC; Jorde UP; Yuzefpolskaya M; Fukuhara S; Mancini DM; Naka Y J Heart Lung Transplant; 2015 May; 34(5):667-74. PubMed ID: 25577566 [TBL] [Abstract][Full Text] [Related]
14. Association of preoperative infections, nasal Staphylococcus aureus colonization and gut microbiota with left ventricular assist device outcomes. Yuzefpolskaya M; Lumish HS; Javaid A; Cagliostro B; Mondellini GM; Bohn B; Sweat A; Onat D; Braghieri L; Takeda K; Naka Y; Sayer GT; Uriel N; Aaron JG; Montassier E; Demmer RT; Colombo PC Eur J Heart Fail; 2021 Aug; 23(8):1404-1415. PubMed ID: 33964186 [TBL] [Abstract][Full Text] [Related]